Oxaprozin or closely related compound for the treatment and prevention of

Details for Australian Patent Application No. 2006228870 (hide)

Owner Astion Pharma A/S

Inventors Weidner, Morten Sloth

Agent FB Rice

Pub. Number AU-A-2006228870

PCT Pub. Number WO2006/102899

Priority 60/695,040 28.06.05 US; PA 2005 00438 30.03.05 DK; 60/694,774 27.06.05 US; PA 2005 00437 30.03.05 DK; PA 2005 00949 27.06.05 DK; PA 2005 00948 27.06.05 DK

Filing date 30 March 2006

Wipo publication date 5 October 2006

International Classifications

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/08 (2006.01) Drugs for dermatological disorders

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/102899 Priority application(s): WO2006/102899

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006228871-Dermatological compositions and salts for the treatment of dermatological diseases

2006228869-Oxaprozin or a closely related compound for the treatment of eczema